August 2019 Back to School

Asthma Watch: Trelegy Ellipta Hits Phase 3 Asthma Marks, Eyes New Indication

August 22, 2019


Pivotal phase 3 trial results show benefits for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) in patients with uncontrolled asthma compared with standard FF/VI (Breo Ellipta) therapy.

Rocklatan From Aerie Pharmaceuticals, Inc

August 15, 2019

Rx Focus

The FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, from Aerie Pharmaceuticals, Inc, for the reduction of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

Mold Can Cause a Persistent Cough

August 14, 2019

Patient Education

Cladosporium, Penicillium, Alternaria, and Aspergillus are the most common molds found in almost all environments.1 These are just a few of the hundreds of thousands of species of fungi.

Stay on Top of Vaccine Recommendations to Counsel Patients

August 07, 2019

From the Chairman its meeting in June, the ACIP made some very interesting suggestions, noting that all children and adolescents between ages 2 and 18 who have not previously received the hepatitis A vaccine should receive a catch-up vaccination and encouraging a change in the human papillomavirus vaccination guidelines to cover men up to age 26.